Talk Presenting Companies (Theatre B) track
Cell and Gene Therapies: Stand Up Therapeutics Inc.
Mon, Nov 9, 2026 · 1:15–1:30 PM CET Koelnmesse
About this session
Stand Up Therapeutics is a clinical-stage biotechnology company in Seoul, Korea, developing in vivo gene therapies for degenerative disease. The company's aim is to return damaged or dysfunctional cells to their pre-disease state, with a particular emphasis on sporadic disease, which accounts for 70-92% of neurodegenerative cases.Cell Resetting Technology (CRT) resets dysfunctional cells to a healthy state by restoring the identity they originally held, reactivating their native master regulators through DNA demethylation rather than reverting them toward pluripotency.
Speaker
-
Founder & Chief Researcher · Stand Up Therapeutics Inc.
Speaker